SARS-CoV-2 seroprevalence in three Kenyan health and demographic surveillance sites, December 2020-May 2021.
<h4>Background</h4>Most of the studies that have informed the public health response to the COVID-19 pandemic in Kenya have relied on samples that are not representative of the general population. We conducted population-based serosurveys at three Health and Demographic Surveillance Syst...
Saved in:
Similar Items
-
Comparative performance of the InBios SCoV-2 DetectTM IgG ELISA and the in-house KWTRP ELISA in detecting SARS-CoV-2 spike IgG antibodies in Kenyan populations [version 2; peer review: 2 approved]
by: Henry Karanja, et al.
Published: (2025-07-01) -
Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in three Kenyan referral hospitals: Repeated cross-sectional surveys 2020-21.
by: Ruth K Lucinde, et al.
Published: (2022-01-01) -
Profile: The Kenya Multi-Site Serosurveillance (KEMIS) collaboration [version 2; peer review: 2 approved]
by: Peninah Munyua, et al.
Published: (2025-02-01) -
The impact of 10-valent pneumococcal conjugate vaccine on the incidence of admissions to hospital with hypoxaemic and non-hypoxaemic pneumonia in Kenyan children.
by: Ilsa L Haeusler, et al.
Published: (2025-01-01) -
Essential plant nutrients impair post‐germination development of Striga in sorghum
by: Immaculate M. Mwangangi, et al.
Published: (2025-03-01)